Seville Football Stadiums Set to Become Mass Vaccination Centres

THE FOOTBALL stadiums of Seville and their hometown rival club Betis are set to become mass vaccination centres with the capacity to jab thousands daily. 

Health authorities are currently examining the football stadiums of Sevilla FC and their hometown rivals Real Betis to prepare for the conversion of both grounds into mass vaccination centres.

The Ramon Sanchez-Pizjuan stadium, home of Sevilla FC, has already been confirmed for conversion into a mass vaccination centre. Located in the eastern Nervion district, the stadium has an estimated capacity to deliver 26,000 jabs per day which would be administered by a team of 100 nurses.

Across the Andalucian capital, in the southern Heliopolis district, experts are analysing the Villamarin stadium – home of Real Betis. The stadium has a similar potential capacity to that of their hometown rivals, and authorities are hopeful that if the two vast new inoculation centres are set up the speed of Seville’s vaccine rollout would be greatly improved.

Currently in the Andalucian capital jabs are being administered in health centres and hospitals while medical staff have been administering doses to nursing home residents and their essential workers.


Thank you for taking the time to read this news article “Seville Football Stadiums Set to Become Mass Vaccination Centres”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Author badge placeholder
Written by

Oisin Sweeney

Oisin is an Irish writer based in Seville, the sunny capital of Andalucia. After starting his working life as a bookseller, he moved into journalism and cut his teeth as a reporter at one of Ireland's biggest news websites. Since joining Euro Weekly News in November, he has enjoyed covering the latest stories from Seville, Spain and further afield - with special interests in crime, cybersecurity, and European politics. Anyone who can pronounce his name first try gets a free cerveza...

Comments